Pyxis Oncology issues milestone-linked common warrants in public offering

Bitget2026/10/02 11:11

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Pyxis Oncology closed a public offering issuing 49,310,352 clinical milestone-linked common warrants with a USD 3.50 exercise price.
Warrants become exercisable only after stockholder approval of a charter amendment increasing authorized common shares and its effectiveness.
Warrants expire on the earlier of five years from the charter amendment effective date or 30 days after the later trigger date.
Cash exercise in full would add about USD 172.6 million gross proceeds, lifting total potential gross proceeds to about USD 282.6 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pyxis Oncology Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610020700PRIMZONEFULLFEED9838369) on October 02, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Pyxis Oncology issues milestone-linked common warrants in public offering

You may also like

Crypto prices